1. Home
  2. HCWB vs DLPN Comparison

HCWB vs DLPN Comparison

Compare HCWB & DLPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HCWB

HCW Biologics Inc.

HOLD

Current Price

$3.30

Market Cap

14.8M

Sector

Health Care

ML Signal

HOLD

Logo Dolphin Entertainment Inc.

DLPN

Dolphin Entertainment Inc.

HOLD

Current Price

$1.10

Market Cap

14.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCWB
DLPN
Founded
2018
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
14.8M
14.6M
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
HCWB
DLPN
Price
$3.30
$1.10
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$35.00
N/A
AVG Volume (30 Days)
459.2K
17.7K
Earning Date
05-15-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
77.87
EPS
0.37
N/A
Revenue
$4,099,750.00
$56,699,389.00
Revenue This Year
N/A
$14.73
Revenue Next Year
N/A
$7.41
P/E Ratio
$10.35
N/A
Revenue Growth
N/A
9.70
52 Week Low
$0.25
$0.99
52 Week High
$7.35
$1.88

Technical Indicators

Market Signals
Indicator
HCWB
DLPN
Relative Strength Index (RSI) 51.53 45.25
Support Level $0.37 $1.05
Resistance Level $3.89 $1.70
Average True Range (ATR) 0.39 0.06
MACD -0.13 0.01
Stochastic Oscillator 8.94 39.39

Price Performance

Historical Comparison
HCWB
DLPN

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing, and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials. The company operates within the U.S.

Share on Social Networks: